Login
  • Bookmark
  • PDF
  • Share
  • CaseIQ

Umesh Sharma And Another Petitioners v. S.G Bhakta And Others S

Bombay High Court
Oct 8, 2002
Smart Summary (Beta)

Structured Summary of the Judgment delivered by N.V. Dabholkar, J.

Factual and Procedural Background

These writ petitions under Article 227 challenged orders of the Chief Judicial Magistrate, Aurangabad dated 14-6-2002. Original Accused 3 and 4 (petitioners) sought recall of the process issued against them in two criminal prosecutions arising from samples of "Scarab Lotion" drawn from traders who stated they had purchased the product from M/s Aristo Pharmaceuticals Ltd. (Accused 5, the Company). The Magistrate rejected applications (referred to as Exts. 33 & 23) to recall process on the ground that petitioners, being the Managing Director and Director respectively, had control over the Company and so were responsible for its acts. Applications for exemption from personal appearance (Exts. 34 & 24) were also rejected; those applications became infructuous after the Magistrate decided the recall applications.

Factual specifics relevant to the prosecutions: (i) In the "first case" a Drugs Inspector drew a sample on 17-11-1993 (Batch No. 85093-G; manufactured July 1993; expiry June 1995); (ii) In the "second case" a Drugs Inspector drew a sample (Batch No. 85082-H; manufactured August 1992; expiry July 1994). The Government Analyst reported that contents of Gamma Benzene Hexachloride and Citrimide exceeded Schedule V limits in both samples, with specific percentages noted in the Analytical Reports dated 7-6-1994. Prosecutions were launched under Section 18(a)(i) read with Section 27 (and Section 34 as regards companies) of the Drugs and Cosmetics Act, 1940.

Legal Issues Presented

  1. Whether the Chief Judicial Magistrate erred in rejecting the petitioners' applications to recall process issued against them, particularly where the complaint lacks specific averments that the petitioners were "in charge of, and responsible to" the Company for conduct of its business at the relevant time (as contemplated by S.34(1) of the Drugs and Cosmetics Act, 1940).
  2. Whether mere designation as Director or Managing Director in the complaint suffices to draw the presumption of vicarious liability under S.34(1), or whether specific allegations of having overall control/being in-charge or of consent/connivance/neglect (as required by S.34(2)) are necessary.
  3. Whether the Magistrate's decision exhibited non-application of mind (procedural irregularity) by failing to consider the specific grounds and precedents relied upon in the petitioners' applications when deciding in their absence.

Arguments of the Parties

Petitioners' Arguments (summarized)

  • The learned Magistrate dealt with and rejected the recall applications on merits while the petitioners and their advocates were absent; this amounted to non-application of mind and failure to consider the actual submissions contained in the applications.
  • The complaint did not contain averments showing Accused 3 and 4 were "in charge of, and responsible to" the Company for its conduct of business on the dates in question; the complaint only named Accused 1 as manufacturing chemist and Accused 2 as quality-control chemist, while Accused 3 and 4 were simply described as Directors (Accused 3 as "Managing Director" and Accused 4 as "Director").
  • Relying on precedent (e.g., State of Haryana v. Brij Lal Mittal; Pannalal Sunderlal Choksi v. State of Maharashtra; and others), mere directorship or the label "Managing Director" without allegations that the person had overall control or that the offence was committed with his consent/connivance is insufficient to proceed against directors under S.34.

Respondent / Magistrate's Position (summarized)

  • The learned Chief Judicial Magistrate observed that petitioners being the Managing Director and Director of the Company were responsible for the Company's acts and had control over it, and therefore rejected the applications to recall process despite their residence being out of station.
  • The prosecution invoked S.34 of the Drugs and Cosmetics Act to proceed against the Directors in addition to the Company and the responsible technical staff.

Table of Precedents Cited

Precedent Rule or Principle Cited For Application by the Court
State of Haryana v. Brij Lal Mittal, 1998 5 SCC 343 Scope of vicarious liability under S.34(1) of the Drugs and Cosmetics Act: mere fact of being a Director does not automatically establish that the person was "in charge of" and "responsible to" the company for conduct of business; such facts must be averred. The Court relied on this principle to hold that the complaint in the present matters lacked allegations that Accused 3 and 4 were in charge or responsible, and therefore the Magistrate should not have continued process against them on the basis of mere directorship.
Pannalal Sunderlal Choksi v. State of Maharashtra, 2000 Cri LJ 4442 (Bombay High Court) Interpretation of S.34 of the Drugs and Cosmetics Act (and S.17 of Prevention of Food Adulteration Act) emphasizing that directors can be proceeded against only if complaint shows they were in charge/responsible or that offence was with their consent/connivance. The Court noted that the learned Single Judge followed the view that bald assertions of directorship are insufficient; applied that reasoning to conclude the complaint did not justify process against Accused 3 and 4.
KPG Nair v. Jindal, 2001 All MR Cri 1206 Under provisions pari materia with S.34 (here S.141 of Negotiable Instruments Act), allegations in complaint must fulfil statutory ingredient that the person was in-charge and responsible to company for conduct of business; absence of such allegations disallows prosecution. The Court used this precedent to support the proposition that, in absence of allegations showing the director was in-charge/responsible at the relevant time, proceedings against him should be quashed.
G.L. Gupta v. D.N. Mehta, 1971 3 SCC 189 Definition of "in-charge": it means overall control of day-to-day business; a director may be a party to policy but not in-charge; manager usually is in-charge of day-to-day business. The Court applied this interpretive principle to hold that legal requirement is overall control of day-to-day business; since complaint lacked such averments against petitioners, process could not be sustained.
Iqbal v. State of Maharashtra, 2002 1 FAC 321 Under the Food Adulteration Act, directors/managers/officers could be proceeded against only if the complaint showed offence was committed with their consent or connivance; absence of such allegations precludes proceedings. The Court noted the learned Single Judge's application of this view and relied on it by analogy to reinforce that complaint must allege consent/connivance or responsibility before prosecuting directors.
Municipal Corporation of Delhi v. Ram Kishan Rohtagi, 1983 1 SCC 1 Distinction between Manager (likely vicariously liable) and Directors (not vicariously liable absent allegations/evidence); court can, in exceptional circumstances, take cognizance later upon additional evidence (S.319 discretion remark). The Court invoked this authority to emphasize that managers may be plainly vicariously liable, whereas directors require specific factual allegations; also to clarify that recalling process does not bar trial court from later taking cognizance if additional evidence is produced.
U.P. Pollution Control Board v. Mohan Meakins Ltd., 2000 3 SCC 745 At the stage of issuing process, the complaint must contain allegations by which Managers or Directors can also be proceeded against; if complaint contains factual averments showing responsibility/connivance, process against directors/managers may be justified. The Court contrasted that in Mohan Meakins the complaint contained specific averments justifying process against directors; here, by contrast, the complaint lacked such averments and therefore process could not be sustained against petitioners.

Court's Reasoning and Analysis

The Court proceeded through the following analytical steps, grounded in statutory text and precedent cited in the record:

  1. Procedural irregularity: The Court accepted petitioners' submission that the learned Magistrate had dealt with and rejected the recall applications on merits in the absence of petitioners and their counsel and, in doing so, had not adequately considered the contents of the applications (including precedents expressly relied upon). The Court characterized that decision-making as "hurried and slipshod" and a non-application of mind.
  2. Statutory framework: The Court identified the relevant statutory provisions — Section 18(1)(i) (prohibition on manufacture for sale of drugs not of standard quality), Section 16(1)(a) (definition of "standard quality"), Section 27 (penalty), Section 3(b) (definition of drug), and crucially Section 34(1) (offences by companies) together with the overriding and evidentiary aspects of sub-section (2).
  3. Legal standard under S.34(1): The Court emphasized that S.34(1) operates by deeming guilty "every person who at the time the offence was committed, was in charge of, and was responsible to the company for the conduct of the business of the company." However, the Court also explained — following authorities — that S.34(1) does not by itself create a presumption that a person merely by being a Director or Managing Director was in charge and responsible; the complaint must contain averments to that effect.
  4. Application to the pleadings: The Court examined the complaint paragraphs relied upon by the prosecution (paras 2, 3 and 16 reproduced in the judgment). The Court found these paragraphs merely identified Accused 3 and 4 as Directors (and Accused 3 as Managing Director) and identified Accused 1 and 2 as the manufacturing chemist and quality control chemist respectively. There were no specific averments that Accused 3 or 4 were "in charge of" or "responsible to" the Company for conduct of business relating to manufacture of the objectionable drug, nor any allegation of consent, connivance or neglect attributable to them.
  5. Distinction between "Director", "Managing Director" and "Manager": Drawing on statutory definitions in the Companies Act (S.2(24) and S.2(26)) and prior case-law, the Court explained that a Managing Director is a Director entrusted with substantial powers of management only if such powers have been conferred by agreement, resolution, or memorandum/articles; the label alone does not establish overall control of day-to-day business. The Court concluded that in the absence of allegations or documentary reference showing delegation of substantial management powers to Accused 3, mere description as "Managing Director" was insufficient to attract S.34(1) liability.
  6. Evidentiary burden in view of S.34(2): The Court noted that S.34(2) (and its overriding effect) obliges the prosecution to indicate and prove that the offence was committed with the consent or connivance of, or was attributable to any neglect on the part of, a Director/Manager/other officer, before the presumption of guilt against such individual arises; only then does the accused bear the onus to show absence of knowledge or exercise of due diligence.
  7. Integration of precedent: The Court reviewed and synthesized authorities (including Brij Lal Mittal, G.L. Gupta, Ram Kishan Rohtagi, Mohan Meakins and others) to articulate the settled principle that at the stage of issuing process the complaint must contain allegations by which directors/managers may be proceeded against; absent such averments, the Court should not allow automatic extension of company liability to directors purely by title.
  8. Conclusion from facts and law: Given the absence of specific allegations that petitioners were in-charge/responsible or that the offence was committed with their consent/connivance, and in view of the Magistrate's procedural lapse in not considering the applications comprehensively, the Court accepted petitioners' contention and held that process against them must be recalled.
  9. Protective clarification: The Court expressly clarified (following the reasoning in Ram Kishan Rohtagi) that recalling process at this stage does not bar the trial court from later exercising discretion to take cognizance of petitioners if compelling additional evidence is produced during trial that establishes a case against them.
  10. Ancillary procedural point: The Court observed that the applications for exemption from personal appearance became infructuous once the recall applications were decided on 14-6-2002, and accordingly challenges to those exemption rejections were moot.

Holding and Implications

Holding: Writ petitions allowed; the process issued against petitioners (original Accused 3 and 4) is recalled.

Implications (direct effects and statements made by the Court):

  • Direct effect on parties: The formal process against the petitioners has been recalled as the complaint lacks the necessary averments to make out prima facie liability of the directors under S.34(1) of the Drugs and Cosmetics Act.
  • Procedural consequence: The applications for exemption from personal appearance became infructuous after the recall decision; the related challenge to rejection of those exemption applications is thus moot.
  • Preservation of trial court discretion: The Court clarified that recall of process does not foreclose the trial court's exceptional statutory power to take cognizance of petitioners later if additional evidence is produced at trial satisfying the court that a case has been made out against them (referencing Ram Kishan Rohtagi). The Court made this explicit as a protective qualification to its order.
  • On precedent and law: The judgment applies existing authorities (as cited) to restate the legal principle that directors are not automatically liable by reason of title alone; specific averments or proof of being in-charge/responsible, or of consent/connivance/neglect, are required to attract vicarious or statutory liability under S.34. The Court did not purport to lay down new law but applied settled principles to the facts before it.

Rule made absolute with the clarification that the trial court may exercise its discretion to proceed against the petitioners if satisfied on additional evidence that a case is made out.

Show all summary ...

The Judgment of the Court was delivered by

N.V Dabholkar, J.— By these writ petitions under Art. 227 of the Constitution, original Accused 3 and 4 challenge the orders passed by learned Chief Judicial Magistrate, Aurangabad on 14-6-2002, in Criminal Case No. 80348 of 1997 (earlier Criminal Case No. 11 of 1995) and Regular Criminal Case No. 179 of 1996 (earlier Criminal Case No. 675 of 1994) below Exts. 33 and 34 in the first matter and Exts. 23 and 24 in the second matter. By orders below Exts. 33 and 23, in the respective criminal cases, learned Chief Judicial Magistrate rejected the applications of petitioners/Accused 3 and 4 requesting to recall the process issued against them on the ground that they were not in charge of the business of the Company, nor responsible to the Company for conduct of the business. Since it was admitted position that Accused 3 and 4 are the Managing Director and Director respectively of M/s Aristo Pharmaceuticals Limited (for short, “the Company”) (original Accused 5), the learned Chief Judicial Magistrate was of the view that they were responsible for the acts of the Company, having control over it, although they reside out of station.

2. So far as applications Exts. 34 and 24 are concerned, the petitioners had requested for exemption from personal appearance till decision of Exts. 23 and 24. Those were rejected in view of disposal of applications Exts. 33 and 23. Even when the matter is now being argued before this Court, since exemption was sought from personal appearance till decision of applications for recall of the process, applications Exts. 34 and 24, with decision of applications Exts. 33 and 23 on 14-6-2002, have become infructuous, so also the challenge to rejection of applications Exts. 34 and 24.

3. Both the matters are taken up for hearing together and are being disposed of by this common judgment, in view of the fact that identical questions of fact and law arise in both the matters and the only variance is regarding date of collection of samples of drugs manufactured by Accused 5 Company.

4. Heard learned counsel for the respective parties. By mutual consent, Rule is made returnable forthwith.

5. The factual matrix giving rise to present criminal cases can be stated in brief as follows: (henceforth for the sake of brevity, criminal case from which Writ Petition No. 261 of 2002 arises is referred to as “first case” and the other one as “second case”).

So far as first case is concerned, Shri P.N Shende, Drugs Inspector, Food and Drugs Administration, Nagpur paid visit to M/s Thakkar Medico Traders, 89, Central Avenue, Nagpur 440 019 on 17-11-1993. He drew a sample of Scarab Lotion of Batch No. 85093-G, manufactured in July 1993, for which the date of expiry was June 1995 by following the prescribed procedure laid down under the Act.

So far as second case is concerned, Shri V.N Ransube, Drugs Inspector visited M/s Maharashtra Medical Stores, 17, Kherwadi Road, Bandra (E), Bombay 400 051 and had drawn a sample of Scarab Lotion of Batch No. 85082-H, manufactured in August 1992 for which the date of expiry was July 1994.

The Government Analyst, upon analysis, sent the Analytical Report No. M-6952/93 and M-2145/93 dated 7-6-1994 in the respective matters reporting in both the matters; “Content of Gamma Benzene Hexachloride and Citrimide in the sample are more than Schedule V limits.”

In the first matter, Gamma Benzene Hexachloride was 124.5% of the labelled amount, whereas it was 128% in the second instance. Similarly Citrimide in the sample of first case was 270% of the labelled amount and it was 226% of the labelled amount in the second case.

Since both the traders from whom the respective samples were collected by respective Drugs Inspectors informed that they had purchased the said drug from the said Company, the prosecutions were launched by the Drugs Inspector, Aurangabad, attached to the office of Joint Commissioner, Aurangabad Division, Food and Drugs Administration, Aurangabad for the offences under S. 18(a)(i) of the Drugs and Cosmetics Act, 1940 (for short, “the said Act” hereinafter). In the said prosecutions, petitioners/original Accused 3 and 4 filed applications Exts. 33 and 23, as discussed earlier, for recalling the process issued against them by the learned Chief Judicial Magistrate, which were rejected by the impugned order dated 14-6-2002 and hence the writ petitions.

6. Apart from the arguments on merits, learned Senior Counsel Shri Gupte for the petitioners, has taken a serious exception to the impugned order on the ground that the impugned orders suffer from non-application of mind, although he conceded that both the applicants as well as their advocates were absent when the learned Judge dealt with the applications. Shri Gupte pointed out that the learned Judge has dealt with the applications on merits and rejected those by observing that petitioners, as the Managing Director and Director respectively, were in control of the Company and therefore, responsible for the acts of the Company. Shri Gupte has taken me through the text of Ext. “C”, which is the copy of application presented before the learned Chief Judicial Magistrate, and pointed out that even in application para 4, reliance was placed upon the judgments State of Haryana v. Brij Lal Mittal 1998 5 SCC 343 as also Pannalal Sunderlal Choksi v. State of Maharashtra 2000 Cri LJ 4442.

7. The first one is the judgment of the Supreme Court and the latter one is the judgment of the learned Single Judge of this Court, both being the cases under the said Act, as the cases in the present writ petitions and in both the matters, the prayer of accused Directors of manufacturing companies was for quashing the complaint. According to Advocate Shri Gupte, the learned Judge while dealing with the applications in absence of petitioners and their counsel, but on merits, could not have ignored the contents of the application and if he was willing to go ahead with the matter in absence of petitioners and their counsel, he was duty-bound to consider the application in its entirety and in any case, he could not have ignored the ratio laid down by the Apex Court and this Court, which was relied upon expressly by the contents in the application.

8. The submission of Senior Counsel Shri Gupte regarding the impugned order, to the above effect are fully justified. The learned Judge has dealt with the matter in a hurried and slipshod manner, without referring to the grounds on which the process was prayed to be recalled and speedy disposal of the application, at the cost of non-consideration of submissions in the application, is required to be deprecated in harsh words.

9. Shri Gupte, Senior Counsel has relied upon those two cases, which were relied upon in the application and in addition couple of more cases. It was argued that by the text of the complaint itself, it was evident that original Accused 1 and 2, the manufacturing chemist and the Assistant Manager, Quality Control were the persons, having control over the manufacture and composition of various ingredients in the drug. Petitioners as Directors had no control over the manufacturing activities, much less there are any averments to that effect in the complaint and therefore, in the light of the ratio laid down by the Apex Court as well as this Court in the cases relied upon, the Magistrate could not have rejected the applications. According to Shri Gupte, these were fit cases wherein process was required to be recalled, so far as original Accused 3 and 4.petitioners are concerned.

10. S. 18(1)(i) of the said Act prohibits manufacture for sale of drug, which is not of standard quality or misbranded, adulterated or spurious. According to S. 16(1)(a) “standard quality” in relation to a drug means that drug which complies with the standard set out in the Second Schedule. S. 27 provides penalty for manufacture, sale etc. of the drug in contravention of the provisions of Ch. IV of the said Act and for the purpose of cases at hand, the residuary cl. (d) of the said section would be applicable. The drug is defined by S. 3(b) of the said Act. None of these provisions are either referred to or disputed by Shri Gupte, Senior Counsel in the present matter.

11. Since the prosecution has relied upon S. 34 of the said Act regarding offences by companies, Shri Gupte, Senior Counsel has referred to text of S. 34(1) and contended that the contents of the complaint do not attract the ingredients of the said section, so as to invite prosecution of Directors i.e petitioners. Said provision reads as follows:

“34. Offences by companies.—(1) Where an offence under this Act has been committed by a company, every person who at the time the offence was committed, was in charge of, and was responsible to the company for the conduct of the business of the company, as well as the company shall be deemed to be guilty of the offence and shall be liable to be proceeded against and punished accordingly:”

12. According to Shri Gupte, Senior Counsel, the complaint does not contain any averment, which will indicate that petitioner Directors were in charge of and responsible to the Company for the conduct of business on the date the drug was manufactured or the day on which the samples of the said drug were collected by the Drugs Inspector. According to Shri Gupte, paras 2, 3 and 16 of the complaint are the only paragraphs, which contain averments in an attempt to fasten the responsibility on the respective accused persons. These paragraphs are being reproduced hereinbelow, for ready reference.

“2. That Accused 1 is the manufacturing chemist who manufactured the ‘not of standard quality’ drug and Accused 2 is the quality control chemist under whose supervision the ‘not of standard quality’ product was analysed.

3. That Accused 3 and 4 are the Directors of M/s Aristo Pharmaceuticals Ltd. situated at E-6, MIDC Chikalthana, Aurangabad.

16. That, the complainant, therefore, charges that Accused 1 and 2 who are in charge of production and testing of the drug ‘not of standard quality’ and Accused 3 and 4 are the Directors of Accused 5 for manufacturing and selling on or about 17-11-1993 a not of standard quality drug and thus Accused 1, 2, 3, 4 and 5 have committed an offence…”

13. The case of KPG Nair v. Jindal 2001 All MR Cri 1206 was a matter under S. 138 of the Negotiable Instruments Act. Application under S. 482 of the Criminal Procedure Code seeking to quash the proceedings was dismissed by the High Court, by holding that averments in the complaint by the respondent Company along with statements of witnesses, prima facie go to show that at the relevant time, the appellant being the Director of the accused Company was also in charge and responsible for the business of the same. In fact, appellant had not signed the cheque, but was sought to be prosecuted in view of S. 141 of the Negotiable Instruments Act in his capacity as Director of the accused Company at one time. It was argued on behalf of the complainant, that it was required to be inferred that appellant was in charge of and responsible to the Company for the conduct of its business. However, nowhere it was stated that on the date when the offence was committed, appellant was in charge or was responsible to the accused Company for conduct of its business. Provisions of S. 141 of the Negotiable Instruments Act are pari materia with the provisions of S. 34(1) of the said Act.

14. It was held by the Supreme Court that the substance of the allegations should necessarily fulfil the requirements of ingredients of S. 141(1) for being proceeded against for the offence, which is alleged to have been committed. According to the Apex Court, the allegations in the complaint did not, either in the express words or with reference to the allegations contained therein, make out a case that at the time of commission of offence, the appellant was in charge of and was responsible to the Company for the conduct of its business. Consequently, the appeal was allowed and the proceedings were quashed.

15. In brief, in absence of allegations regarding appellant being in-charge of and responsible to the Company, the Director, it was held, cannot be prosecuted.

16.State of Haryana v. Brij Lal was the second case relied upon by petitioners. This was a complaint for the offence under S. 27 of the said Act. The process issued against three Directors of the manufacturer company, was quashed by the High Court, as filed after the expiry of shelf life of the drug. The Apex Court, although held that quashing was not justified on that ground, upheld the order on different grounds. The Apex Court considered the scope and ambit of vicarious liability that can be imposed by virtue of S. 34(1) of the said Act and observed that simply because the person is Director of the company, it does not necessarily mean that he fulfills the above requirements. From the complaint in question, it was found that except the bald statement that respondents were Directors of the manufacturer, there was no other allegation to indicate that prima facie they were in-charge of the company and also responsible to the company for the conduct of business.

17. Thus, as a result of observations in both these cases, it can be said that although S. 34(1) creates a presumption as to the guilt, once it is shown that the person was in charge of and responsible to the company for conduct of business, the section by itself does not create a presumption that the person merely by being a Director was in charge and responsible to the company, which fact is required to be averred in the complaint and duly proved.

18. In the matter of Iqbal v. State of Maharashtra 2002 1 FAC 321 the learned Single Judge followed the same view. In this matter under the Food Adulteration Act, one Gyan Bahadur, Supervisor was nominee of the company by specific resolution passed on 31-5-1993 under S. 17(2) of the Food Adulteration Act. So far as Directors of the company were concerned, it was observed by the learned Single Judge that Director, Manager, Secretary or other officers could be proceeded against only if the complaint showed that the offence was committed with the consent or connivance of these persons and in absence of allegations regarding the same, they could not be proceeded against. In this matter, there were no averments against the Directors, alleging that the offence was committed with their consent or connivance.

19.Pannalal v. State of Maharashtra is a judgment of learned Single Judge of this Bench. Two criminal writ petitions under Art. 227 of the Constitution read with S. 482 of the Criminal Procedure Code, seeking quashment of proceedings under the Prevention of Food Adulteration Act and Drugs and Cosmetics Act are dealt with in the said judgment. The Court was seized of interpretation of S. 34 of the Drugs and Cosmetics Act, as also S. 17 of the Prevention of Food Adulteration Act, which provisions are pari materia, except the distinction that under the Drugs and Cosmetics Act, there is no provision to declare a nominee of the company as under S. 17(2) of the Prevention of Food Adulteration Act.

20. The petitioners in both the writ petitions were Directors of the respective companies and their main grievance was that they were not in charge of and were not responsible to the company for the conduct of business. While considering the said submission, learned Single Judge has relied upon observations of the Apex Court in the matter of G.L Gupta v. D.N Mehta 1971 3 SCC 189 wherein the Supreme Court had interpreted the provisions of S. 23-C of the Foreign Exchange Regulation Act, 1947, which provision is analogus to the provision of S. 34 of the Act of 1940 and S. 17 of the Act of 1954. The Supreme Court observed as follows: (SCC p. 190, para 6)

“It seems to us that in the context a person ‘in-charge’ must mean that the person should be in overall control of the day to day business of the company or firm. This inference follows from the wording of S. 23-C(2). It mentions Director, who may be a party to the policy being followed by a company and yet not be in-charge of the business of the company. Further it mentions manager, who usually is in-charge of business but not in overall charge. Similarly, the other officers may be in-charge of only some part of the business.”

21. It was held that what is legally required is overall control over the day-to-day business of the company and the firm. If this element is present then only the directors of the company are responsible. Since in the reported matter, there was no whisper in the complaints that petitioners were in charge of and were also responsible to the Company for the conduct of business, the applications were allowed and orders of issuing summons as well as the proceedings before the trial court were quashed.

22. In the matter of Municipal Corpn. of Delhi v. Ram Kishan Rohtagi 1983 1 SCC 1 Food Inspector had filed a prosecution against the Manager (Respondent 1) and Directors (Respondents 2 to 5) of M/s Upper Ganges Sugar Mills, along with the Company itself. The appeal by special leave was preferred by the Municipal Corporation of Delhi against the judgment of the Delhi High Court quashing the proceedings taken against Respondents 1 to 5. The only point that was canvassed before the Supreme Court was that on the allegations in the complaint a clear-cut case was made out against all the respondents and the trial court ought not to have quashed the proceedings on the ground that the complaint did not disclose any offence. According to respondents, even taking the allegations of the complaint ex facie true, no case for trial was made out at all. The main clause of the complaint which was the subject-matter of the dispute read as follows:

“5. Accused 3 is the Manager of Accused 2 and Accused 4 to 7 are the Directors of Accused 2 and as such, they were in-charge of and responsible for conduct of the business of Accused 2 at the time of sampling.”

Accused 3 was Respondent 1 Manager and Accused 4 to 7 Directors were Respondents 2 to 4 of the Company, Respondent 5. The Supreme Court held: (SCC p. 7, para 15)

“15. So far as the Manager is concerned, we are satisfied that from the very nature of his duties it can be safely inferred that he would undoubtedly be vicariously liable for the offence; vicarious liability being an incident of an offence under the Act. So far as the Directors are concerned, there is not even a whisper nor a shred of evidence nor anything to show, apart from the presumption drawn by the complainant, that there is any act committed by the Directors from which a reasonable inference can be drawn that they could also be vicariously liable.”

23. Consequently, the order of the High Court was upheld so far as the Directors were concerned and it was set aside as against the Manager, Respondent 1.

24. Taking into consideration the ratio laid down, which is identical in all the cases relied upon by the learned counsel for the petitioners, at the stage of issuing process, the complaint must contain the allegations by which the Directors of the company can also be proceeded against, when the company is alleged to be guilty of offence. In the absence of such allegations, there cannot be a presumption that the Directors were in charge of and responsible to the Company for conduct of the business of the Company.

25. The averments fixing the liability upon individuals, as contained in the complaint are reproduced in para 8 (ante). In fact, the contents in para 16 of the complaint relating to petitioners also depict some incompleteness in clause, “… and Accused 3 and 4 are the Directors of Accused 5 for manufacture and selling on/or about 17-11-1993 not of standard quality drug….” and do not contain any averments attributing their roll of persons in charge of day to day business. In para 3 also it is simply said that Accused 3 and 4 are the Directors of the Company. There are no specific allegations or averments, not even in the form of bald statement or reproduction of relevant clause from S. 34 to the effect, “in charge of and responsible to the Company for conduct of business”, much less as against Accused 1 and 2, in para 2 of the complaint, wherein, it is specifically said that Accused 1 is Manufacturing Chemist and Accused 2 is the Quality Control Chemist, under whose supervision the product was respectively manufactured and analysed.

26. In view of the ratio from various cases relied upon and absence of specific averments against petitioners/Accused 3 and 4 in the complaint, the arguments advanced by the learned counsel for petitioners will have to be accepted.

27. Observations of the Supreme Court in the matter of Ram Kishan Rohtagi have compelled me to invite attention of the learned counsel to the fact that in the complaint Ext. “A” Accused 3 and 4 are described in a different manner, so far as their status vis-à-vis Company is concerned. Accused 4 is described as “Director” whereas, Accused 3 is described as “Managing Director”. All the ratios relied upon and conclusions drawn by me above, would be mutatis mutandis applicable to Accused 4, but it becomes necessary to consider whether Accused 3 who is described as Managing Director, can be treated on the same footing as the Director.

28. I have drawn attention of learned counsel for petitioners to the dictionary meaning of the word “management” which means administration, control, supervision etc. It was argued by Shri Gupte, Senior Counsel that merely because Accused 3 is described as “Managing Director”, that by itself will not be sufficient to draw a presumption that he was in charge of or responsible to the conduct of business of the Company. He may be having control over matter such as policy decision, but not on the production or manufacture of the objectional drug. In the absence of specific averments that he was in charge of and responsible to the conduct of the Company, so far as it related to manufacture of the drug, he would not be liable for prosecution along with Company and there are no averments in the complaint attracting ingredients required by S. 34(1) and therefore, mere description of Accused 3 as Managing Director will not be sufficient to sustain the process issued against him.

29. In the matter of Ram Kishan Rohtagi the Apex Court was concerned with the case of Manager and not that of Managing Director. For the purpose of finding out distinction in the roles played by these two authorities in the life of a company, I have referred to the definitions of these terms from the Companies Act, 1956. S. 2(24) defines the word “Manager” as follows:

“2. (24) ‘manager’ means an individual (not being the managing agent) who, subject to the superintendence, control and direction of the Board of Directors, has the management of the whole, or substantially the whole, of the affairs of a company, and includes a Director or any other person occupying the position of a manager, by whatever name called, and whether under the contract of service or not;”

S. 2(26) defines, “Managing Director” thus;

“2. (26) ‘Managing Director’ means a Director, who by virtue of an agreement with the company or a resolution passed by the company in general meeting or by its Board of Directors or, by virtue of its memorandum or articles of association is entrusted with substantial powers of management which would not otherwise be exercisable by him, and includes a Director, occupying the position of a Managing Director by whatever name called:”

30. The distinction between Manager and Managing Director is that, while the Manager by virtue of his office has the management of whole or substantially whole of the affairs of the company, the Managing Director has to be entrusted with such powers of the management as may be thought fit. The powers of management are required to be delegated upon the Managing Director, either by an agreement with the company or by a resolution passed by the Board of Directors in its general meeting or by virtue of its memorandum or articles of association. It is not the name by which the person is called but the position he occupies and the functions and duties which he discharges that determine whether in fact, he is in-charge of and responsible to the company or not.

31. Taking this distinction into consideration, there need not be a presumption of Accused 3 being in-charge of or responsible to the Company for production of objectional drug. Although Food Inspector has obtained information from the Company itself that Respondent 3 is the Managing Director, further details such as agreement between him and the Company or resolution passed by the Board of Directors etc. by which substantial powers of management are conferred upon Accused 3, are neither obtained nor incorporated in the complaint.

32. On reference to S. 34 as a whole, there is a presumption of being guilty against the person, who is in-charge of and responsible to the company, and such a person is liable to be punished unless he proves that offence was committed, without his knowledge or in spite of exercise of due diligence to prevent the commission of offence. By virtue of sub-s. (2) which is given overriding effect over sub-s. (1) by non obstante clause in its opening part, the prosecution is obliged to prove that the offence has been committed with the consent or connivance of or is attributable to any neglect on the part of any Director, Manager, Secretary or other officer of the company, before drawing a presumption of guilt against such individual.

33. Taking into consideration the overriding effect given to sub-s. (2) it will be the responsibility of the prosecution to first indicate and prove that objectionable drug was manufactured with the consent or in connivance of the Managing Director or production of the said drug is attributable to any neglect on the part of the Managing Director, only thereafter, he would be presumed to be the person in-charge of and responsible to the company for conduct of business and will be obliged to establish absence of knowledge or exercise of due diligence in order to seek exoneration.

34. In the recent judgment in the case of U.P Pollution Control Board v. Mohan Meakins Ltd. 2000 3 SCC 745 the order issuing process passed by the Chief Judicial Magistrate against the Directors of M/s Mohan Meakins for the offence under the Water (Prevention and Control of Pollution) Act, 1974 was quashed by the Sessions Judge. The Pollution Control Board moved the High Court in revision, which was dismissed by the High Court. While dismissing the appeal preferred by the Pollution Control Board and directing the trial court to proceed with the case, the Supreme Court observed in para 12: (SCC p. 752)

“12. In the above context what is to be looked at during the stage of issuing process is whether there are allegations in the complaint by which the Managers or Directors of the Company can also be proceeded against, when the Company is alleged to be guilty of the offence.”

The complaint contained averments that accused persons i.e Directors/Managers/Partners of M/s Mohan Meakins were responsible for constructing the proper works and plant for the treatment of their highly polluting trade effluent so as to confirm to the standard laid down by the Board. It also alleged that accused persons were deliberately avoiding to abide by the provisions of the said Act. It was in the light of factual averments in the complaint, the Supreme Court was of the view that the Directors and Managing Directors of the Company were liable to be proceeded against according to law.

35. In the matter at hand, except the bare statement that Accused 3 and 4 are the Directors of the Company, there are no averments that they are in charge of or responsible to the Company, not even in the form of bald statement.

36. Before closing, reference to paras 17 and 19 of the judgment in the matter of Ram Kishan Rohatagi is inevitable. After referring to the powers to proceed against other persons appearing to be guilty of offence as contained in S. 319 of the Criminal Procedure Code, 1973 in para 17 of the judgment, the Supreme Court made following observations in para 19: (SCC p. 8)

“19. In these circumstances, therefore, if the prosecution can at any stage produce evidence which satisfies the court that the other accused or those who have not been arrayed as accused against whom proceedings have been quashed have also committed the offence the Court can take cognizance against them and try them along with the other accused. But, we would hasten to add that this is really an extraordinary power which is conferred on the court and should be used very sparingly and only if compelling reasons exist for taking cognizance against the other person against whom action has not been taken. … We leave the entire matter to the discretion of the court concerned so that it may act according to law. We would, however, make it plain that the mere fact that the proceedings have been quashed against Respondents 2 to 5 will not prevent the court from exercising its discretion if it is fully satisfied that a case for taking cognizance against them has been made out on the additional evidence led before it.”

37. The writ petitions are, therefore, allowed and the process issued against petitioners shall stand recalled, however, by clarifying, as in the case of Ram Kishan Rohtagi that mere fact that process against the petitioners is recalled will not prevent the trial court from exercising its discretion, if it is fully satisfied that the case for taking cognizance against them has been made out on the additional evidence that may be led before it.

Rule is accordingly made absolute, with clarification.